Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
09/23/2004 | WO2004080964A1 Indole derivatives useful for the treatment of diseases |
09/23/2004 | WO2004080462A1 c-Kit KINASE INHIBITOR |
09/23/2004 | WO2004064708A3 Solution for nostril wash |
09/23/2004 | WO2004052365A3 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
09/23/2004 | WO2004041258A3 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
09/23/2004 | WO2004014293A3 Combination of anti-muscarinic agents and non-glucocorticoid steroids |
09/23/2004 | WO2003094836A3 Methods and products for enhancing immune responses using imidazoquinoline compounds |
09/23/2004 | WO2003082268A3 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
09/23/2004 | WO2003011219A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
09/23/2004 | US20040186320 Antioxidant nitroxides and nitrones as therapeutic agents |
09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
09/23/2004 | US20040186157 inhibiting kinases; for treating or preventing neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia |
09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
09/23/2004 | US20040186127 E.g., 7-(5-(2-(cyclohexylmethylamino)ethyl)indol-2-yl), 2-methyl-3H-imidazo(4,5-b)pyridine; antiinflammatory agents; antiproliferative agents; autoimmune diseases; reperfusion injuries; osteoporosis; bone disorders; antimetastasis agents |
09/23/2004 | US20040186126 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
09/23/2004 | US20040186106 such as (S)-N-{{(1R, 2R)-2-{4-{[2-(4-Methyl-piperazin-1-yl)-benzimidazol-1-yl]methyl}-phenyl}-cyclohex-1-yl} carbonyl}-phenylglycinamide; for treatment of ischemic brain disorders |
09/23/2004 | US20040186104 Novel pyridinone and related heterocyclic derivatives |
09/23/2004 | US20040186096 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
09/23/2004 | US20040185507 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
09/23/2004 | US20040185500 Use of disease-associated gene |
09/23/2004 | US20040185122 Selective COX-2 inhibition from edible plant extracts |
09/23/2004 | US20040184993 allows the modulation of the mass median aerodynamic diameter of the aerosol particles on actuation of the inhaler to a value which is suited for the pulmonary administration |
09/23/2004 | CA2517569A1 Indole derivatives useful for the treatment of diseases |
09/22/2004 | EP1460066A1 Piperazine compounds |
09/22/2004 | EP1460064A1 Indole-2-carboxamide derivatives useful as beta-2 agonists |
09/22/2004 | EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
09/22/2004 | EP1458864A1 Tgf-beta-specific covalently closed antisense molecule |
09/22/2004 | EP1458752A2 Polypeptides of pseudomonas aeruginosa |
09/22/2004 | EP1458746A2 Cyclic tetrapeptide compound and use thereof |
09/22/2004 | EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
09/22/2004 | EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
09/22/2004 | EP1458721A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
09/22/2004 | EP1458718A1 Quinolinones as prostaglandin receptor ligands |
09/22/2004 | EP1458717A1 Aroyl pyridinones |
09/22/2004 | EP1458715A1 Novel compounds |
09/22/2004 | EP1458712A2 Novel compounds |
09/22/2004 | EP1458706A1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
09/22/2004 | EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof |
09/22/2004 | EP1458682A1 1,4-dihydro-1,4-diphenylpyridine derivatives |
09/22/2004 | EP1458679A2 Pyrrolidine derivatives as prostaglandin modulators |
09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
09/22/2004 | EP1458405A1 Use of fk506 and analogues for treating allergic diseases |
09/22/2004 | EP1458397A1 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure |
09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
09/22/2004 | EP1458387A2 Orodispersible tablets containing fexofenadine |
09/22/2004 | EP1458379A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
09/22/2004 | EP1458370A1 Treatment of faecal incontinence and other conditions with 1r,2s-methoxamine |
09/22/2004 | EP1458367A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
09/22/2004 | EP1289505B1 Process of producing a stable pharmaceutical composition containing micronized formoterol |
09/22/2004 | EP1274709B1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
09/22/2004 | EP1259495B1 Indane derivatives and their use as cell adhesion inhibitors |
09/22/2004 | EP1242073B1 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
09/22/2004 | EP1146874B1 Vitronectin receptor antagonist |
09/22/2004 | EP1144402B1 Substituted oximes and hydrazones as neurokinin antagonists |
09/22/2004 | EP1124801B1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
09/22/2004 | EP1100781B1 High affinity ligands for nociceptin receptor orl-1 |
09/22/2004 | EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
09/22/2004 | EP0841900B1 Pharmaceutical composition for detecting lung disease |
09/22/2004 | EP0830347B1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
09/22/2004 | CN1531592A Process for preparation of neutrophil inhibitory factor |
09/22/2004 | CN1531549A Pharmaceutical use for secreted bacterial effector proteins |
09/22/2004 | CN1531546A Peptide compounds |
09/22/2004 | CN1531536A Process for preparation of pyrazolo[4,3-D] pyrimidine derivative |
09/22/2004 | CN1531535A Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
09/22/2004 | CN1531529A 4-(benzylidenje-amino)-3-(methylsulfanyl)-4H-(1,2,4) triazin-5-one derivatives having PDE-IV inhibiting and TNF-antagonistic effect for treatment of cardiac diseases and allergies |
09/22/2004 | CN1531528A Dibenzocycloheptene compound |
09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
09/22/2004 | CN1530366A Sulphonic acid amide for regulating bast peptide activity and derivative thereof |
09/22/2004 | CN1530128A Chinese medicine preparation for treating acute and chronic pharyngitis, preparing method thereof |
09/22/2004 | CN1530120A Preparing method for compound Rhododendron dauricum dropping pellet |
09/22/2004 | CN1530097A Use of trivalency chromium in preparation of drug against allergic rhinitis |
09/22/2004 | CN1167710C Pyrrolidincarbonylamino cyclic disulfides |
09/22/2004 | CN1167707C 2,3-O-isopropylidene derivatives of monosaccharides as cell adhesive inhibitors |
09/22/2004 | CN1167678C 新颖的维生素d类似物 Novel analogues of vitamin d |
09/22/2004 | CN1167667C Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
09/22/2004 | CN1167466C Oral medicinal preparation |
09/22/2004 | CN1167449C Medicine for nasosinusitis |
09/22/2004 | CN1167448C Cough relieving medicated wine |
09/22/2004 | CN1167445C Chinese herbal medicinal preparation for treating rhinitis and nasosinusitis |
09/21/2004 | US6794515 Synthesis of 2-alkylcysteine via substituted thiazoline amide |
09/21/2004 | US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease |
09/21/2004 | US6794416 Treatment of chronic obstructive pulmonary disease including chronic bronchitis, emphysema and asthma in humans that smoke or smoked cigarettes using aerosol or nebulizing device with or without concommitant treatment |
09/21/2004 | US6794406 For therapy and prophylaxis of arteriosclerosis and hypercholesterolaemia |
09/21/2004 | US6794403 Substituted benzoxazoles as estrogenic agents |
09/21/2004 | US6794391 Inhibitors of phosphodiesterase (pde) isoenzymes; useful for treatment of respiratory disorders such as asthma. |
09/21/2004 | US6794386 β-amino acid compounds as integrin antagonists |
09/21/2004 | US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof |
09/21/2004 | US6794380 Amide derivatives |
09/21/2004 | US6794365 Inhibitors of the blood clotting enzyme factor xa; treating thromboembolic diseases; trifluoroacetic acid salt of 2-(4-carbamimidoyl-benzyl)-n-((1-carbamoyl-4-guanidino-butylcarbamoyl) -cyclohexyl-methyl)-n',n'-dimethyl-malonamide |
09/21/2004 | US6793936 Delivers an active ingredient in a pulsed or bimodal manner. |
09/21/2004 | CA2146757C Stabilization of fluorocarbon emulsions |
09/21/2004 | CA2100381C N-derivatives of (phenylethyl-.beta.-ol) amine, a process for their preparation and pharmaceutical compositions containing the same |
09/21/2004 | CA2076226C Substituted 1-pyrimidinylacetamide compounds |
09/16/2004 | WO2004078756A2 Jnk inhibitors |
09/16/2004 | WO2004078754A1 5-phenylthiazole derivatives and their use as p13 kinase inhibitors |